Dabrico Inc Bourbonnais, IL - 60914

Dabrico Inc is categorized under Pharmaceutical Machinery Manufacturers in Bourbonnais, IL and active since 1979.

Dabrico Inc was established in 1979, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Pharmaceutical Machinery Manufacturers business, which does work in the B2B market, and is classified as a Pharmaceutical Machinery Manufacturers, under code number 3339990 by the NAICS.

If you are seeking more information, feel free to contact Efrain Davila, President at the company’s single location by writing to 1555 Commerce Drive, Bourbonnais, Illinois IL 60914 or by phoning (815) 939-7798. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Dabrico Inc
Contact Person: Efrain Davila, President
Address: 1555 Commerce Drive, Bourbonnais, Illinois 60914
Phone Number: (815) 939-7798
Website Address: dabrico.com
Annual Revenue (USD): $2.500.000 to $4.999.999
Founded: 1979
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Pharmaceutical Machinery Manufacturers
SIC Code: 3559
NAICS Code: 3339990
Share This Business:

Dabrico Inc was started in 1979 to provide professional Pharmaceutical Machinery Manufacturers under the SIC code 3559 and NAICS code 3339990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Efrain Davila, President for inquiries that concern Dabrico Inc by calling the company number (815) 939-7798, as your correspondence is most welcome. Additionally, the physical location of the single location of Dabrico Inc can be found at the coordinates 41.17336,-87.85953 as well as the street address 1555 Commerce Drive in Bourbonnais, Illinois 60914.

For its online presence, you may visit Dabrico Inc’s website at dabrico.com and engage with its social media outlets through on Twitter and on Facebook.